N@N

Market Maker Surveillance Report. CATS, HCM, CPRX, KCG, JNUG, IHRT, Winning Stocks With Lowest Price Friction For Wednesday, M

March 15, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 5387 companies with "abnormal" market making, 4483 companies with positive Friction Factors and 1722 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Catasys Inc. (OTC:CATS), Hutchison China MediTech Limited (NASDAQ:HCM), Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX), KCG Holdings Inc. (NYSE:KCG), Direxion Trust Shs Direxion Daily Junior Gold Miners Index Bull 3X ETF (NYSE:JNUG), iHeartMedia Inc. (PINK:IHRT). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  CATS    $0.460    0.34%     149,351      57.63%    109,372      42.20%    39,979       869     
  HCM     $4.540    0.28%     47,340       34.85%    44,315       32.62%    3,025        7       
  CPRX    $0.470    0.40%     9,926,708    39.51%    9,680,900    38.53%    245,808      5,230   
  KCG     $3.080    0.22%     159,827      20.23%    100,541      12.72%    59,286       192     
  JNUG    $1.900    0.33%     55,221,054   40.59%    52,901,946   38.89%    2,319,108    12,206  
  IHRT    $0.280    0.24%     51,300       58.50%    35,965       41.01%    15,335       548     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows CATS with a dollar gain Wednesday of $0.46000 and a Friction Factor of 869 shares. That means that it only took 869 more shares of buying than selling to move CATS higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Catasys Inc. (OTC:CATS) - Catasys, Inc. provides specialized healthcare management services to health plans and other third party payors through a network of licensed and company managed healthcare providers. It offers OnTrak integrated substance dependence solutions to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company s OnTrak substance dependence programs include medical and psychosocial interventions, a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services. Its OnTrak program includes various components, such as member identification and engagement, enrollment/referral, provider network, outpatient medical treatment, outpatient psychosocial treatment, care coaching, monitoring and reporting, and proprietary Web-based clinical information platform. The company was formerly known as Hythiam, Inc. and changed its name to Catasys, Inc. in March 2011. Catasys, Inc. was founded in 2000 and is based in Los Angeles, California..

Hutchison China MediTech Limited (NASDAQ:HCM) - Hanover Capital Mortgage Holdings, Inc. (Hanover), incorporated on June 10, 1997, is a specialty finance company organized as a real estate investment trust (REIT). Hanover is engaged in three principal lines of business, which are conducted through three primary operating units: Hanover (the REIT), Hanover Capital Partners Ltd. (HCP) and HanoverTrade, Inc. (HT). REIT, operated through Hanover, invests in various securities to generate net interest income. HCP provides consulting and outsourcing services marketed to the mortgage industry. HT offers loan sale advisory (LSA) services and technology solutions for the mortgage industry.

Effective January 1, 2006, both HCP and a subsidiary of Hanover, Hanover Capital Partners 2, Inc (HCP2) merged with and into HT with HT remaining as the surviving entity. The newly combined entity bears the official corporate name of Hanover Capital Partners 2, Ltd. (HCP-2); however, the Company has, to assist in continuing to monitor its business segments and provides its various service offerings, and has retained the trade names: HanoverTrade, Hanover Capital Partners and Servicing Source. Hanover Capital Securities, Inc. (HCS) is, as a result of the merger, a subsidiary of the HCP-2 entity.

As of December 31, 2005, Hanover had two non-consolidated special purpose entities formed, during the year ended December 31, 2005. Hanover Statutory Trust I and Hanover Statutory Trust II were created for the purpose of issuing and selling, to third parties, trust-preferred securities that are secured with Hanover's junior subordinated notes.

Hanover (The REIT)

Hanover's principal business is to generate net interest income by investing in subordinate mortgage-backed securities (Subordinate MBS), collateralized by pools of prime single-family mortgage loans, and purchasing whole single-family mortgage loans for investment, securitization and resale. Hanover also maintains a portfolio of whole-pool Fannie Mae and Freddie Mac mortgage-backed securities (Agency MBS). Hanover focuses on increasing the earnings potential in its investments by leveraging its purchases of mortgage securities with borrowings obtained primarily through the use of 30-day revolving repurchase agreements, which are established by sales with agreements to repurchase. The borrowings under the repurchase agreements are generally at 50-97% of the security's fair market value, depending on the security, and are adjusted to market value each month as the repurchase agreements are reestablished. Other mortgage security or mortgage loan financing is accomplished through the use of committed lines of credit, usually under repurchase agreements or through the creation of collateralized mortgage obligations (CMOs). Hanover also, on occasion, receives income from real estate investment management services that can include asset management, due diligence, and administrative services.

As part of its REIT operations, Hanover maintains an equity investment in a joint venture entity, HDMF-I LLC (HDMF-I), formed to purchase, service, manage and ultimately resell or otherwise liquidate pools of sub- and non-performing one- to four-family residential mortgage loans. Hanover also receives a management fee from HDMF-I.

Hanover Capital Partners Ltd.

HCP provides services to commercial banks, mortgage banks, government agencies, credit unions and insurance companies. The services provided include loan due diligence (credit and compliance) on a full range of mortgage products, quality control reviews of newly originated mortgage loans, operational reviews of loan origination and servicing operations, mortgage assignment services, loan collateral reviews, loan document rectification, and temporary staffing services.

The delivery of the HCP consulting and outsourcing services usually requires an analysis of a block or pool of loans on a loan-by-loan basis. This requires the use of technology developed and owned by HCP. HCP may also perform certain due diligence services and analysis of mortgage assets acquired by Hanover.

Hanove.

Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) - Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for people with rare debilitating diseases. Its lead product candidate is Firdapse, a proprietary form of amifampridine phosphate, which completed Phase III clinical trial for the treatment of patients with Lambert-Eaton Myasthenic syndrome; and is in small blinded clinical trial to treat Congenital Myasthenic syndromes, as well as is in Phase II/III clinical trial for the treatment of MuSK-antibody positive myasthenia gravis. The company also develops CPP-115, a GABA aminotransferase inhibitor that is in Phase Ib clinical trial for the treatment of epilepsy and other neurological indications, such as complex partial seizures and Tourette s disorder; and CPP-109 to treat Tourette s disorder. It has a strategic collaboration with BioMarin Pharmaceutical Inc. for the development of Firdapse. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida..

KCG Holdings Inc. (NYSE:KCG) - KCG Holdings, Inc., an independent securities firm, provides various services designed to address trading needs across asset classes, product types, and time zones. The company operates through three segments: Market Making, Global Execution Services, and Corporate and Other. The Market Marking segment principally consists of market making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. This segment commits capital on a principal basis by offering to buy securities from, or sell securities to, broker dealers, banks, and institutions. Its principal trading comprise direct to clients, as well as in a supplemental capacity on exchanges, electronic communications networks (ECNs), and alternative trading systems. This segment also participates on various equity and futures exchanges; trades in various domestic electronic options exchanges; and handles specialized orders and transacts on the OTC Bulletin Board and the Alternative Investment Market of the London Stock Exchange. The Global Execution Services segment provides agency execution services and trading venues for agency-based execution-only trading in global equities, fixed income, futures, and options to institutions, banks, and broker dealers. This segment offers agency-based execution-only trading services through various access points, such as algorithmic trading and order routing in various equities and options; institutional sales traders executing program, block and riskless principal trades in global equities, and exchange traded funds; fixed income ECN that offers trading applications; and an ATS for U.S. equities. The Corporate and Other segment invests principally in strategic trading-related opportunities. KCG Holdings, Inc. is headquartered in Jersey City, New Jersey..

Direxion Trust Shs Direxion Daily Junior Gold Miners Index Bull 3X ETF (NYSE:JNUG) - .

iHeartMedia Inc. (PINK:IHRT) - .

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net